Lobe SciencesLOBEF -7.24% FCF Yield % is -13.47 as of Jun. 28, 2026. The stock has 2 warning signs investors should review. Among 1,418 Biotechnology companies, Lobe Sciences ranks worse than 57.9% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Lobe Sciences FCF Yield % Related Terms
Lobe Sciences FCF Yield % Historical Data
* Premium members only.
The historical data trend for Lobe Sciences's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Lobe Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lobe Sciences FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lobe Sciences's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Lobe Sciences's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lobe Sciences (LOBEF) has a FCF Yield % of -13.47 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lobe Sciences and its competitors. According to the industry distribution chart, Lobe Sciences ranks #821 out of 1418 companies in the Biotechnology industry, placing it in the top 57.9%.
Is Lobe Sciences' FCF Yield % too high?
Lobe Sciences' current FCF Yield % is -13.47. Based on the distribution chart, Lobe Sciences ranks #821 out of 1418 companies in the Biotechnology industry, which is below the industry midpoint.
How does Lobe Sciences' FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lobe Sciences ranks #821 out of 1418 companies for FCF Yield %. This places Lobe Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lobe Sciences and its competitors. Lobe Sciences's current FCF Yield % is -13.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lobe Sciences stock overvalued right now?
Lobe Sciences (LOBEF) has a current FCF Yield % of -13.47. The current FCF Yield % is -13.47. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Lobe Sciences (LOBEF), the current FCF Yield % is -13.47 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle cell disease. Through its subsidiaries, the company also holds a majority interest in the development of Conjugated Psilocin for potential use in neurological and psychiatric indications. The company operates in one reportable segment, being the biopharmaceutical development of new medicines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LOBEF has been successfully added to your 